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Abstract
In 2017, the term “persistent postural-perceptual dizziness” (PPPD) was coined by the Bárány Society, which provided 
explicit criteria for diagnosis of functional vertigo and dizziness disorders. PPPD can originate secondarily after an organic 
disorder (s-PPPD) or primarily on its own, in the absence of somatic triggers (p-PPPD). The aim of this database-driven 
study in 356 patients from a tertiary vertigo center was to describe typical demographic and clinical features in p-PPPD 
and s-PPPD patients. Patients underwent detailed vestibular testing with neurological and neuro-orthoptic examinations, 
video-oculography during water caloric stimulation, video head-impulse test, assessment of the subjective visual vertical, 
and static posturography. All patients answered standardized questionnaires (Dizziness Handicap Inventory, DHI; Vestibu-
lar Activities and Participation, VAP; and Euro-Qol-5D-3L). One hundred and ninety-five patients (55%) were categorized 
as p-PPPD and 162 (45%) as s-PPPD, with female gender slightly predominating (♀:♂ = 56%:44%), particularly in the 
s-PPPD subgroup (64%). The most common somatic triggers for s-PPPD were benign paroxysmal positional vertigo (27%), 
and vestibular migraine (24%). Overall, p-PPPD patients were younger than s-PPPD patients (44 vs. 48 years) and showed 
a bimodal age distribution with an additional early peak in young adults (about 30 years of age) beside a common peak at 
the age of 50–55. The most sensitive diagnostic tool was posturography, revealing a phobic sway pattern in 50% of cases. 
s-PPPD patients showed higher handicap and functional impairment in DHI (47 vs. 42) and VAP (9.7 vs. 8.9). There was 
no difference between both groups in EQ-5D-3L. In p-PPPD, anxiety (20% vs. 10%) and depressive disorders (25% vs. 9%) 
were more frequent. This retrospective study in a large cohort showed relevant differences between p- and s-PPPD patients 
in terms of demographic and clinical features, thereby underlining the need for careful syndrome subdivision for further 
prospective studies.
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Introduction
Functional (somatoform) dizziness is a frequent cause of 
chronic, ongoing dizziness seen in specialized dizziness 
units. It considerably burdens patients in the absence of 
an acute peripheral or central vestibular pathology [1, 2]. 
The clinical terminology for functional dizziness changed 
frequently in the past and was comprised of heterogeneous 
terms. The Bárány Society redefined chronic functional diz-
ziness under the new name of persistent postural-perceptual 
dizziness (PPPD) in 2017 ([3], Table 1). This new defini-
tion is based on the long-standing expert knowledge of sev-
eral forms of chronic functional dizziness, such as phobic 
postural vertigo [4–6], visual vertigo [7], chronic subjec-
tive dizziness [8–10], and space-motion discomfort [11]. It 
comprises the essence of each entity mentioned above with 
long-lasting non-rotatory dizziness, unsteadiness, and fluctu-
ations of symptoms with stimulus-triggered provocation and/
or exacerbation (e.g., visual stimuli). Common precipitating 
conditions for PPPD are earlier vestibular experiences, initi-
ated especially by organic peripheral or central vestibular 
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disorders or psychological distress [12–15]. On the other 
hand, patients with psychiatric comorbidities, predominantly 
depressive or anxiety disorders, are also known to have a 
higher risk of developing functional dizziness [10, 16, 17].
However, little is known about the clinical characteristics 
of chronic functional dizziness syndromes resulting from 
preceding somatic (vestibular) disorders (i.e., secondary, 
s-PPPD; e.g., Huppert et al. [6]), and those originating on 
their own as the primary cause of the illness (i.e., primary, in 
absence of a preceding somatic trigger, p-PPPD). Although 
at first glance the clinical presentation of p- and s-PPPD 
appears very similar, clinical experience suggests variable 
accentuation in terms of functionality, handicap, psychiatric 
comorbidities, and introspection in relation to the underly-
ing cause [14–16, 18]. Therefore, with this study in a large, 
well-investigated PPPD cohort, we aimed to elucidate typi-
cal demographical and clinical features, as well as poten-




Using the DizzyReg database [19, 20], we screened 470 
patients with chronic functional dizziness diagnosed at a ter-
tiary dizziness center (German Center for Vertigo and Bal-
ance Disorders, DSGZ, Munich, Germany) over 24 months 
between 2015 and 2017. Inclusion criteria were a newly 
diagnosed or known form of chronic functional dizziness, 
disease duration of at least 3 months, age above 18 years, 
and written informed consent. Additional exclusion criteria 
for participation were as follows: acute unilateral or chronic 
bilateral vestibulopathy (as assessed by caloric testing, 
video head-impulse test, and clinical examination), relevant 
neurological and neurodegenerative diseases (e.g., encepha-
lomyelitis or severe polyneuropathy).
In retrospect, 356 patients fulfilled the current diagnostic 
criteria for PPPD ([3], Table 1) and were included in the 
statistics. All patients underwent a psychiatric investiga-
tion, as well as a detailed neurological and neuro-orthoptic 
examination including fundus photography by a scanning 
laser ophthalmoscope (SLO) for the measurement of ocular 
torsion and electronic assessment of the subjective visual 
vertical (SVV). Furthermore, all patients underwent either 
video-oculography at rest to determine spontaneous nys-
tagmus and during water caloric stimulation (VOG-CS), 
video head-impulse test (vHIT), or both for evaluation of 
peripheral vestibular function, as well as static posturog-
raphy. These detailed examinations were especially useful 
to exclude acute vestibular tone imbalance, e.g., ocular tilt 
reaction. Assisted by a neurologist, all patients answered a 
short questionnaire for vestibular disorders regarding vertigo 
and dizziness phenomenology and associated symptoms. All 
patients also completed the Dizziness Handicap Inventory 
(DHI), Vestibular Activities and Participation (VAP), and 
the Euro-Qol-5D-3L questionnaire (EQ-5D-3L).
Depending on the information about an ascertained pre-
ceding somatic/vestibular trigger (e.g., benign paroxysmal 
positional vertigo) provided by the patients themselves or 
available from medical documentation, each patient was 
classified as either s- or p-PPPD.
Protocol approval and patient consent
The study was approved by the appropriate ethics commit-
tee, and has, therefore, been performed in accordance with 
the ethical standards laid down in the 1964 Declaration of 
Helsinki and its later amendments. The DizzyReg database 
prospectively collects all information from the clinical 
Table 1  Current diagnostic criteria of the Bárány Society for persistent postural-perceptual dizziness (PPPD)
All five criteria (a–e) must be fulfilled to make the diagnosis of PPPD
(a) One or more symptoms of dizziness, unsteadiness, or non-spinning vertigo on most days for at least 3 months
  Symptoms last for prolonged (hours long) periods of time, but may wax and wane in severity
  Symptoms need not be present continuously throughout the entire day
(b) Persistent symptoms occur without specific provocation, but are exacerbated by three factors:
  Upright posture
  Active or passive motion without regard to direction or position
  Exposure to moving visual stimuli or complex visual patterns
(c) The disorder is precipitated by conditions that cause vertigo, unsteadiness, dizziness, or problems with balance including acute, episodic, or 
chronic vestibular syndromes, other neurologic or medical illnesses, or psychological distress
  When the precipitant is an acute or episodic condition, symptoms settle into the pattern of criterion as the precipitant resolves, but they may 
occur intermittently at first, and then consolidate into a persistent course
  When the precipitant is a chronic syndrome, symptoms may develop slowly at first and worsen gradually
(d) Symptoms cause significant distress or functional impairment
(e) Symptoms are not better accounted for by another disease or disorder
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patient records or from discharge letters, subject to informed 
consent from the patient.
Instrument‑based vestibular testing
Caloric testing for the function of the horizontal semicir-
cular canals was done using 30 °C cool and 44 °C warm 
water irrigation measuring peak slow-phase velocity (SPV) 
by video oculography (EyeSeeCam®). Values less than 5°/s 
SPV were considered pathological. Side asymmetry during 
caloric testing was assessed by the vestibular paresis for-
mula of Jongkees [21]. Values above 30% were considered 
pathological. Subjective visual vertical (SVV), a test for an 
acute dysfunction of graviceptive pathways, was measured 
in a motor-operated hemispheric dome as deviation from 
the objective vertical axis in degrees. A mean deviation of 
more than ± 2.5° from the true vertical was considered a 
pathological SVV deviation.
Standardized vHIT measurements of the semicircular 
function in the high-frequency range were obtained in a 
bright room with a red target affixed at eye level at a distance 
of 1.8 m using the EyeSeeCamHIT® system (Interacoustics, 
Middelfart, Denmark) [22], with the procedure as described 
in [23]. A vHIT gain of less than 0.7 was considered patho-
logical. The vHIT gain asymmetry index was calculated 
as follows: (difference of ipsilateral and contralateral gain/
sum of ipsilateral and contralateral gain) × 100%. A vHIT 
gain asymmetry index of more than 10% was considered 
pathological.
Posturographic measurements were performed using a 
stabilometer platform (Kistler 9261A; Kistler Group, Win-
terthur, Switzerland) in an upright standing position. Dis-
placement of center of gravity was assessed by the total sway 
path for x-, y-, and z-directions (for x- and y-axis: m/min and 
for z-axis: kN/min). Balance control was evaluated using 
a well-established posturography protocol comprising ten 
different conditions with increasing difficulty. In addition 
to the regular analysis, sway patterns were analyzed over 
all conditions by an artificial neuronal network [24, 25] and 
categorized as normal, phobic, cerebellar, orthostatic, or 
vestibular patterns. The “phobic pattern” is typically char-
acterized by a poor performance (i.e., increased body sway) 
under easy conditions and almost normal performance at 
higher difficulty levels or with an additional dual task [26].
Standardized Questionnaires
The DHI is a well-established measure for self-perceived 
limitations posed by vertigo and dizziness [27]. A total of 
25 questions are used to evaluate different aspects of dis-
ability. The range of the DHI is from 0 to 100, with a score 
of 0 being the best possible score (0 = no, 2 = sometimes, 
4 = yes). It is divided into 3 subcategories: emotional (36 
points), functional (36 points), and physical handicap (28 
points). The higher the score, the greater the problems.
Functioning and participation were assessed with the 
VAP short form. The VAP is specifically designed for 
patients with vertigo and dizziness und is validated for dif-
ferent countries and languages [28, 29]. It measures func-
tioning and participation in two separate subscales, each 
consisting of 6 items (ordinal Likert scale 0–4). Using 
weights derived from Rasch analysis, the first scale has a 
range of 0–23 points and the second of 0–20 points, with 
higher scores indicating more restrictions.
Health-related quality of life was assessed with the 
generic EuroQoL five-dimensional questionnaire (EQ-
5D-3L) [30]. This is subdivided into five health state dimen-
sions, namely mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression, with each dimension having 
three levels: no problems, some problems, and extreme 
problems. These health states were converted into EQ5D 
scores using the German time trade-off scoring algorithm. 
The resulting total score ranges from 0 to 1, with higher 
scores indicating better quality of life. The EQ-5D-3L visual 
analog scale (VAS) was documented in a score of 0–100, 
with a score of 100 reflecting the best self-reported health 
condition.
Statistical analysis
All continuous variables are reported with mean values and 
standard deviation and categorical variables with absolute 
and relative frequencies. The median was used for ordinal 
variables. All variables were checked for normal distribu-
tion (Kolmogorov–Smirnov test) and equality of variances. 
Group comparison of parametric variables (differences of 
mean) was assessed by the student’s t test. In case of non-
normality, differences were evaluated by the Mann–Whitney 
U test. For differences of nominal variables between two 
groups (2 × 2 contingency tables), we performed Fisher’s 
exact test. When comparing more than two groups or fac-
tors, a chi-squared test was used. Correlations were meas-
ured with Pearson’s r. For all statistical tests, a two-sided p 
value below 0.05 was considered significant. All statistical 
calculations were performed with the Statistical Package for 
the Social Sciences (SPSS®), version 25 (IBM Corporation) 
and with R 3.6.1. (R Core Team 2019; https ://www.r-proje 
ct.org/index .html).
Results
Out of 356 PPPD patients, 195 patients (55%) were catego-
rized as p-PPPD and 162 (45%) as s-PPPD. Figure 1 sum-
marizes all somatic triggers of vertigo in s-PPPD patients.
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All PPPD patients
For the whole patient cohort, the mean disease duration 
was 2.8 years before admission. The mean age was 46 years 
(range 18–81 ± 14 years), slightly favoring females (56%). 
The predominant vestibular sensation was lightheadedness 
(75%), followed by unsteadiness (72%). 49% reported addi-
tional subjective rotational vertigo sensations. The most 
common symptom-length of a vertigo episode was > 48 h 
(33%), followed by 1–12 h (28%). The vertigo/dizziness 
episodes were often accompanied by other symptoms, e.g., 
headache (50%) or head pressure (46%), phono- or pho-
tophobia (39%), tinnitus (40%), or nausea (27%). Many 
patients reported experiences of motion sickness (59%), 
memory and concentration deficits (50%), as well as sus-
ceptibility to visual triggers (28%). The most common vis-
ual triggers were quick movements of surroundings (36%), 
crowds (24%), design of buildings (22%), and flashes of light 
(17%). About half of all patients had mild, but regular alco-
hol consumption (51%). Interviews at admission and docu-
mentation revealed an overall high prevalence of psychiatric 
comorbidities with depressive episodes (18%) and anxiety 
disorders (15%) in the past or present, but only 31 patients 
(9%) were currently on antidepressant medication. For more 
details, see Table 2.
Vestibular testing revealed that no PPPD patient showed 
signs of acute vestibular tone imbalance (i.e., no spontane-
ous nystagmus in VOG or SLO, no nystagmus provoked 
by head-shaking, no ocular tilt reaction). SVV measure-
ments were normal in the great majority of patients with an 
overall mean SVV deviation of 1.3° ± 1.07°. Forty patients 
(13%) showed borderline mean values slightly above 2.5° 
(3.37° ± 0.82°; range 2.53°–5.31°), but with great intra-indi-
vidual variance in between the adjustments not providing 
evidence of a clinically relevant vestibular imbalance. 70% 
of all patients tolerated warm and cold caloric semicircular 
canal testing with reliable results. Caloric testing was abnor-
mal in only 31 out of the 249 patients (12%) due to older 
residual unilateral peripheral lesions resulting in an overall 
regular mean side asymmetry index of 16% and mean SPV 
of the induced nystagmus of 13°/s. vHIT was performed in 
90% of all patients and showed comparable results with an 
abnormal asymmetry index in 39 out of 320 patients (12%). 
Mean vHIT gain at 60 ms was normal on both sides (0.97 
left and 0.91 right side) and the mean vHIT asymmetry 
index was also normal (4.8%). 70% of all PPPD patients 
completed posturography sufficiently, of which 49% were 
normal, 50% showed a typical phobic/functional, and only 
1% a vestibular sway pattern. Posturography sway path cor-
related moderately with patient age for all sway directions 
(x-, y- and z-axis) with r = 0.320 (p < 0.001) and showed only 
inconsistent or weak correlations with standardized ques-
tionnaires (e.g., sway path y-axis and DHI total score with 
r = 0.207; p = 0.002). For more details, see Table 3.
All patients answered the standardized questionnaires 
EQ-5D-3L, VAP short form, and DHI (Table 4). The mean 
VAS score of the EQ-5D-3L was reduced to 58 ± 20 points 
(age- and country-related population norm 78 points), and 
the mean EQ-5D-3L index was reduced to 0.80 ± 0.22 (age- 
and country-related population norm; 0.90) [30]. The VAP 
mean ordinal subscale 1 reflecting functioning was 9.3 ± 3.1 
points and the mean ordinal subscale 2 reflecting participa-
tion was 8.2 ± 3.2 points, indicating a considerable overall 
impairment. The highest handicap was scored in the VAP 
Fig. 1  Somatic triggers for 
secondary functional dizziness. 
Pie chart of somatic triggers 
for secondary PPPD (n = 162) 
reported as relative percentages. 
Benign paroxysmal positional 
vertigo (BPPV), vestibular 
migraine, and acute unilateral 
vestibulopathy were the most 
common preceding organic 
diseases. Examples of relatively 
rare other organic triggers were 
mal de debarquement syndrome, 
vestibular paroxysmia, or supe-
rior canal dehiscence syndrome. 
TIA transient ischemic attack
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categories “focusing attention” (1.81 ± 1.11), “walking long 
distances” (1.47 ± 1.28), and “bending over” (1.47 ± 1.11). 
The DHI scores were all elevated: total score 44.5/100 
(± 18.9), emotional subscore 16.2/36 (± 7.5), functional sub-
score 17.4/36 (± 8.5), and physical subscore 11.3/28 (± 6.5).
Comparative analyses in primary and secondary 
PPPD patients
Although both types of PPPD occurred at any age, there 
were significant differences in age distribution (Kolmogo-
rov–Smirnov test; p = 0.037) (Table 2): the mean age in 
p-PPPD was 44 years (range 18–81 years) vs. 48 years 
(range 19–77 years) in s-PPPD (Student’s t test: p = 0.022). 
Even though both patient groups showed a corresponding 
frequency peak at 50–55 years of age, in p-PPPD, there was 
an additional bimodal peak in the age curve at 25–30 years 
(Fig. 2). s-PPPD patients were more often female (64% vs. 
49%; p = 0.005), and showed a higher rate of additional rota-
tional vertigo sensations (67% vs. 34%; p < 0.001). There 
was no difference regarding the length of vertigo episodes. 
p-PPPD patients were more prone to visual stimuli as ver-
tigo triggers (35% vs. 19%; p = 0.001), and showed a trend 
towards a higher frequency of regular alcohol consumption 
(56% vs. 46%; p = 0.055). Psychiatric comorbidities were 
more common in p-PPPD than in s-PPPD patients in terms 
of depressive (25% vs. 9%; p < 0.001), and anxiety disorders 
(20% vs. 10%; p = 0.008).
Due to the preceding organic disease, vestibular test-
ing remained abnormal significantly more often in s-PPPD 
Table 2  Demographics and 
patient characteristics
Demographics and patient characteristics for the whole patient group as well as for the primary and sec-
ondary PPPD subgroups separately. Significant differences between p- and s-PPPD are printed in bold
SD  standard deviation







Age in years (mean, SD) 45.8 ± 14.2 44.2 ± 14.6 47.7 ± 13.6 0.022
Gender (% female) 55.9 49.0 64.2 0.005
Disease duration in years (mean, SD) 2.8 ± 3.3 2.8 ± 3.3 2.8 ± 3.3 0.924
Psychiatric comorbidities
 Depressive disorder (%) 17.7 24.7 9.3 < 0.001
 Anxiety disorder (%) 15.4 20.1 9.9 0.008
Regular alcohol consumption (%) 51.3 56.0 45.6 0.055
Type of vertigo
 Rotational (%) 48.6 33.5 66.7 < 0.001
 Unsteadiness (%) 71.6 76.3 66.0 0.034
 Lightheadedness (%) 74.2 75.8 72.2 0.467
Length of vertigo episodes
 < 2 min (%) 16.0 14.9 17.3 0.565
 2–20 min (%) 17.4 15.5 19.8 0.327
 20–60 min (%) 9.8 8.2 11.7 0.288
 1–12 h (%) 28.1 30.9 24.7 0.236
 12–48 h (%) 6.5 8.8 3.7 0.081
 > 48 h (%) 33.4 34.6 32.5 0.735
Sensitivity to passive motion (%) 59.0 55.7 63.0 0.194
Susceptibility to visual triggers (%) 27.8 35.1 19.1 0.001
History of falls (last 12 months, %) 22.4 18.8 26.7 0.095
Accompanying symptoms
 Headache (%) 49.7 45.9 54.3 0.136
 Head pressure (%) 45.8 44.8 46.9 0.749
 Nausea (%) 26.7 23.2 30.9 0.118
 Phono-/photophobia (%) 39.3 36.6 42.6 0.276
 Dysesthesia (%) 28.7 32.5 24.1 0.099
 Transient loss of hearing (%) 14.0 9.8 19.1 0.014
 Tinnitus (%) 39.6 38.1 41.4 0.587
Memory and/or concentration deficits (%) 49.7 51.0 48.1 0.596
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patients (e.g., mean SPV of caloric nystagmus, mean vHIT 
gain, as well as asymmetry indices of caloric stimulation 
and vHIT) (Table 3). There was no difference regarding 
mean SVV deviation; also, borderline SVV adjustments 
with great intra-individual variance were equally distrib-
uted. In both patient groups, posturography revealed a 
phobic pattern in about 50%.
Both handicap questionnaires for vestibular functioning 
(DHI and VAP subscale 1, Fig. 3) showed significantly 
higher scores in s-PPPD patients (DHI total: 47.3 vs. 
42.1; p = 0.014; VAP: 9.7 vs. 8.9; p = 0.038). Especially 
the physical (e.g., quick movements, turning around) and 
functional (e.g. working, social life) subscores of the 
DHI were remarkably increased in s-PPPD compared to 
p-PPPD with 12.7 vs. 10.1 (< 0.001) and 18.8 vs. 16.3 
(p = 0.008), respectively. There was no significant differ-
ence between p- and s-PPPD regarding quality of life, as 
measured by EQ5D-3L VAS or the EQ5D-3L index.
Discussion
The key findings of our monocentric, database-driven, ret-
rospective study in 356 PPPD patients concerning typical 
demographic characteristics, clinical features, and vestibular 
diagnostics with regard to primary (p-PPPD) or secondary 
(s-PPPD) functional dizziness development were as follows:
1. The mean age of p-PPPD patients was significantly 
lower than that of s-PPPD patients (44.4 vs. 47.7 years). 
Besides a common age peak in both subgroups in older 
adults of 50–55 years of age, p-PPPD showed an addi-
tional peak in age distribution in young adults between 
25 and 30 years (bimodal peak) (Fig. 2).
2. PPPD genera l ly  prefer red  female  gender 
(♀:♂ = 56%:44%), especially in the s-PPPD subgroup 
(64%).
Table 3  Instrument-based vestibular diagnostics
Results of instrument-based vestibular testing for the whole patient group, as well as for primary and secondary PPPD subgroups separately. Sig-
nificant differences between p- and s-PPPD are printed in bold
SPV peak slow-phase velocity, SD standard deviation, SVV subjective visual vertical, vHIT video head-impulse test





Caloric stimulation (mean SPV, SD, °/sec.) 12.7 ± 6.7 14.4 ± 7.1 11.1 ± 5.9 0.004
Caloric stimulation (mean side asymmetry index, SD) 15.6 ± 11.5 13.6 ± 9.3 18.0 ± 13.5 0.004
Abnormal caloric testing (%) 12.4 6.1 21.3 < 0.001
SVV deviation (mean in°, SD) 1.32 ± 1.07 1.32 ± 1.05 1.32 ± 1.10 0.986
vHIT gain 60 ms left (mean ratio, SD) 0.97 ± 0.13 0.98 ± 0.13 0.95 ± 0.13 0.018
vHIT gain 60 ms right (mean ratio, SD) 0.91 ± 0.16 0.92 ± 0.15 0.89 ± 0.16 0.031
vHIT (mean side asymmetry index, SD) 4.78 ± 4.49 4.66 ± 4.43 4.92 ± 4.59 0.603
Abnormal vHIT (%) 12.2 7.6 18.2 0.006
Posturography firm ground, eyes open (EO)
 Sway path x-direction (m/min) 0.69 ± 0.40 0.69 ± 0.33 0.70 ± 0.48 0.908
 Sway path y-direction (m/min) 0.84 ± 0.34 0.88 ± 0.38 0.80 ± 0.27 0.064
 Sway path z-direction (kN/min) 0.23 ± 0.09 0.23 ± 0.08 0.22 ± 0.09 0.861
Posturography firm ground, eyes closed (EC)
 Sway path x-direction (m/min) 0.72 ± 0.42 0.73 ± 0.39 0.70 ± 0.46 0.538
 Sway path y-direction (m/min) 1.11 ± 0.62 1.12 ± 0.64 1.11 ± 0.60 0.704
 Sway path z-direction (kN/min) 0.23 ± 0.14 0.23 ± 0.13 0.23 ± 0.14 0.95
Posturography foam rubber, eyes open (FEO)
 Sway path x-direction (m/min) 1.05 ± 0.53 1.05 ± 0.47 1.05 ± 0.59 0.916
 Sway path y-direction (m/min) 1.42 ± 0.86 1.45 ± 0.96 1.38 ± 0.72 0.558
 Sway path z-direction (kN/min) 0.28 ± 0.27 0.30 ± 0.34 0.26 ± 0.13 0.211
Posturography foam rubber, eyes closed (FEC)
 Sway path x-direction (m/min) 1.66 ± 0.89 1.67 ± 0.84 1.66 ± 0.95 0.982
 Sway path y-direction (m/min) 2.36 ± 1.32 2.42 ± 1.46 2.23 ± 1.11 0.472
 Sway path z-direction (kN/min) 0.42 ± 0.35 0.44 ± 0.42 0.39 ± 0.26 0.25
Posturography phobic pattern (%) 49.8 49.7 50.0 1.000
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3. In about half of all s-PPPD cases, preceding BPPV 
(27%) and vestibular migraine (24%) were the trigger-
ing diseases, followed by acute unilateral vestibulopathy 
in about 16% (Fig. 1).
4. p-PPPD patients showed psychiatric comorbidities sig-
nificantly more often than s-PPPD patients, e.g., anxiety 
(20% vs. 10%) and depressive disorders (25% vs. 9%).
5. s-PPPD were more handicapped and functionally 
impaired in daily activities as assessed by DHI and VAP 
(Fig. 3). However, quality of life was equally reduced in 
both patient groups.
6. A surprisingly high number of PPPD patients scored 
additional subjective rotational vertigo sensations beside 
the ongoing symptoms, not only in the s-PPPD, but also 
in the p-PPPD subgroup (67% vs. 34%).
7. In general, p-PPPD patients reported significantly higher 
susceptibility to visual triggers (e.g., crowds and quick 
movements of surroundings; 35% vs. 19%).
Table 4  Standardized 
questionnaires
Results of the dizziness handicap inventory (DHI), the Vestibular Activities and Participation question-
naire (VAP), and the Euro-Qol-5D-3L questionnaire (EQ-5D-3L) for the whole patient group as well as for 
the primary and secondary PPPD subgroups separately. Significant differences between p- and s-PPPD are 
printed in bold
QoL  quality of life, VAS visual analog scale, SD standard deviation




PPPD (n = 162)
p value
DHI (mean, SD)
 Total score 44.5 ± 18.9 42.1 ± 19.3 47.3 ± 18.3 0.014
 Emotional subscore 16.2 ± 7.5 16.2 ± 7.9 16.2 ± 7.1 0.927
 Functional subscore 17.4 ± 8.5 16.3 ± 8.5 18.8 ± 8.4 0.008
 Physical subscore 11.3 ± 6.5 10.1 ± 6.4 12.7 ± 6.5 < 0.001
VAP short version (mean, SD)
 Subscale 1 total 9.3 ± 3.1 8.9 ± 3.1 9.7 ± 3.1 0.038
  1 Focusing attention 1.81 ± 1.11 1.78 ± 1.08 1.85 ± 1.14 0.570
  2 Lying down 1.00 ± 1.10 0.79 ± 0.97 1.24 ± 1.18  < 0.001
  3 Standing up 1.15 ± 1.05 1.14 ± 1.04 1.16 ± 1.07 0.863
  4 Bending over 1.47 ± 1.11 1.29 ± 1.08 1.68 ± 1.12 0.001
  5 Lifting objects 1.07 ± 1.06 0.99 ± 1.12 1.16 ± 1.08 0.130
  6 Sports 1.61 ± 1.04 1.58 ± 1.03 1.66 ± 1.05 0.454
 Subscale 2 total 8.2 ± 3.2 8.2 ± 3.2 8.2 ± 3.2 0.981
  7 Walking long distances 1.47 ± 1.28 1.49 ± 1.37 1.44 ± 1.17 0.703
  8 Climbing stairs 1.38 ± 0.86 1.32 ± 0.89 1.46 ± 0.82 0.143
  9 Running 1.00 ± 0.61 0.90 ± 0.64 1.03 ± 0.56 0.062
  10 Moving around 1.03 ± 1.07 1.03 ± 1.10 1.03 ± 1.03 0.992
  11 Traveling as passenger 1.35 ± 1.18 1.33 ± 1.22 1.38 ± 1.14 0.647
  12 Driving a car or riding a bike 1.38 ± 1.02 1.40 ± 1.01 1.36 ± 1.04 0.769
EQ5D-3L
 QoL VAS (mean percentage, SD) 57.7 ± 19.7 58.2 ± 19.4 57.2 ± 20.1 0.651
 QoL summary index (mean, SD) 0.80 ± 0.22 0.79 ± 0.24 0.82 ± 0.20 0.126
Fig. 2  Age distribution density curve in primary and secondary 
PPPD. Primary (blue) and secondary PPPD (green) show a common 
peak at 50–55  years of age, whereas p-PPPD shows an additional 
peak in in young adults between 25 and around 30 years of age
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Our PPPD cohort showed a higher prevalence of p-PPPD 
(55% vs. 45%). Thus, even though a psychiatric explora-
tion, careful history-taking, and a vestibular examination 
routinely took place in our patients, a preceding organic 
vestibular disease potentially triggering the secondary psy-
chosomatic disease could only be found in the minority of 
patients. Comparable reports on frequency distribution are 
rare. The only available study by Staab and Ruckenstein 
from 2007 [10] in 345 patients with chronic subjective diz-
ziness of uncertain cause, also seen in a tertiary balance 
center, reported in about one third of patients no neurooto-
logic or other medical condition explaining the symptoms 
(e.g., potentially comparable to our p-PPPD subgroup), 
whereas in the majority of cases (approximately two thirds) 
mainly central or peripheral vestibular deficits, migraine, 
traumatic brain injury, or dysautonomia/dysrhythmia were 
evident. The shift towards a higher portion of p-PPPD cases 
in our study might be best explained by variant patient inclu-
sion criteria (patients with currently relevant vestibular dys-
function, e.g., due to unilateral vestibulopathy with acute 
vestibular tone imbalance or chronic bilateral vestibular 
failure, were excluded), and referral conditions (e.g., refer-
ral to our center only by a resident medical specialist, ENT 
doctor, or neurologist), as well as by changes in diagnostic 
criteria for organic diseases over time.
The mean age of all PPPD patients is in line with previ-
ous case series in functional dizziness [5, 10]. The older 
mean age in s-PPPD can be best explained by the prerequi-
site of a preceding organic disease, which often favors older 
ages, e.g., BPPV [31]. Although p- and s-PPPD can occur 
at any ages, both groups showed a peak of the age distribu-
tion curve at 50–55 years. Interestingly, p-PPPD patients 
had an additional early peak around the age of 30 years, 
thereby potentially indicating different mechanisms generat-
ing chronic functional vertigo. The age divergence between 
s- and p-PPPD fits nicely with two psychosomatic follow-up 
studies in smaller patient cohorts that reported an average 
age of 52 years in s-PPPD [32] and 42 years in p-PPPD 
[33]. Furthermore, incidences of somatoform and anxiety 
disorders are reported to often favor younger age, with a 
pronounced onset age peaking in 20–40 year-olds [34, 35].
In fact, our p-PPPD patients showed psychiatric comor-
bidities, e.g., anxiety and depressive disorders, significantly 
more often than the s-PPPD patients (20% vs. 10%; 25% vs. 
9%). However, the overall percentage of psychiatric comor-
bidities in our cohort was relatively low compared to studies 
applying detailed psychiatric test procedures (e.g., structured 
clinical interviews, SCID), and thus reporting prevalence 
rates of up to 50–60% [10, 36]. In our study, psychiatric 
comorbidity rates were based on written or verbal infor-
mation provided by the patients themselves, or were newly 
diagnosed by experienced neurologists when the patients 
visited our center, and were in line with earlier data show-
ing a low agreement between the diagnosis of neurologists 
and SCID interviews for psychiatric disorders [37]. How-
ever, one may speculate that hidden psychiatric comorbidi-
ties among our PPPD cohort might potentially influence 
the relation between p- and s-PPPD. Nevertheless, our 
results emphasize the importance of clinical screening for 
psychiatric comorbidities in PPPD patients in general, and 
especially in younger adults without central or peripheral 
vestibulopathies.
Overall, female sex was slightly predominant in this 
PPPD cohort, especially in s-PPPD patients. This effect 
might be partly explained by female preponderance in some 
organic vertigo disorders, such as vestibular migraine [38, 
39] or BPPV [31, 38, 39]. However, earlier studies not only 
in functional dizziness [5, 10], but also in other somatoform 
diseases with neurological symptoms, e.g., somatoform pain 
disorder [40] or non-epileptic seizures [41], also report a 
concurrent predominance of female gender, the reason for 
which might be complex.
Dizziness experience in p-PPPD and s-PPPD appeared 
very similar in terms of disease duration, length of episodes, 
Fig. 3  Boxplots of handicap, functioning, and participation in pri-
mary and secondary PPPD. The a Dizziness Handicap Inventory 
(DHI) total score and subscores (emotional, functional, physical), 
as well as b Vestibular Activities and Participation (VAP) subscales 
(1 = functioning and 2 = participation) in primary and secondary 
PPPD, both showing significantly higher impairment in s-PPPD than 
in p-PPPD in terms of the DHI total score (*p = 0.014), the DHI 
physical (+p < 0.001) and functional subscores (p = 0.008), as well as 
the VAP subscale 1 (*p = 0.038). n.s. not significant. Whiskers indi-
cate 95% confidence intervals
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history of falls, and overall accompanying symptoms. How-
ever, a strikingly high number of patients not only in the 
s-PPPD group (67%, most likely due to organic rotational 
vertigo attacks induced by MD, VM or BPPV), but also 
in the p-PPPD group (34%) reported additional rotational 
vertigo sensations. This appears clinically important and 
underlines the fact that the subjective clinical sensations 
described by laypersons with functional dizziness might be 
more varied than actually reflected by the diagnostic criteria 
requiring prolonged dizziness, unsteadiness, or non-spinning 
vertigo. Clinicians should therefore be very careful with 
chief classification on the basis of the patients’ description 
of their symptoms and should search for psychiatric comor-
bidity, especially in those reporting rotational vertigo, but 
not fulfilling the diagnostic criteria for an organic vertigo 
syndrome. The traditional rule that rotational vertigo does 
not occur without spontaneous or gaze-evoked nystagmus at 
the time it is experienced could help in finding the correct 
diagnosis [42].
Furthermore, p-PPPD showed significantly more suscep-
tibility to visual triggers (e.g., crowds and quick movements 
of surroundings) than s-PPPD, most probably due to a more 
focused self-perception with increased sensitivity regarding 
visual inputs. s-PPPD reported an objectively higher handi-
cap in daily activities (DHI and VAP score), particularly in 
terms of physical und functional domains, due to their pre-
existing or ongoing vestibular disorders (e.g., vertigo attacks 
by VM or MD), and in accordance with abnormal vestibu-
lar testing (calorics, vHIT). However, all remaining deficits 
were centrally compensated when patients were included in 
this study, which is reflected by similar normative results for 
posturography and SVV adjustment in both groups.
Skills and vestibular function were more preserved in 
p-PPPD, but the subjective symptom burden remained high 
and remarkable differences between p- and s-PPPD in terms 
of life quality as assessed by EQ5D-3L were lacking. How-
ever, overall quality of life was significantly reduced in both 
groups (VAS 58%) compared to healthy subject collectives, 
which is in line with earlier reports [43, 44]. The discrep-
ancy between the high subjective burden in PPPD and the 
objective vestibular function is underlined by the lack of a 
significant correlation between DHI, VAP, and QoL scores 
and objective neurophysiological parameters (e.g., in vHIT 
and caloric testing). This is in line with earlier findings in 
patients with PPPD/somatoform vertigo that showed high 
fear of falling but not an objectively increased risk of falling 
in gait analyses [45].
BPPV (27%) followed by VM (24%) and acute unilat-
eral vestibulopathy (16%) were the most important triggers 
for the development of s-PPPD. This result is partly in line 
with earlier studies. In their earlier study from 1995 on 
154 patients with phobic postural vertigo, Huppert and co-
workers also reported BPPV to be the most often associated 
organic vestibular disorder (44%) followed by acute unilat-
eral vestibulopathy (32%) [6]. However, the diagnosis of VM 
was not established at that time [39]. A prospective study 
in organic vestibular diseases over one year also reported 
a significantly higher prevalence of psychiatric comorbid-
ity, especially in patients with vestibular migraine, but not 
in those with BPPV [46]. Furthermore, another longitudi-
nal study confirmed in a larger sample size that especially 
patients with VM are at risk of developing ongoing diz-
ziness and psychological strain compared to other entities 
[47]. Thus, the high rate of preceding BPPV as a trigger for 
PPPD was unexpected. One may speculate that it is due to a 
snapshot at the time of the patients’ appearance in our outpa-
tient unit, and that secondary functional dizziness in BPPV 
might fade away more rapidly when BPPV is successfully 
treated. The latter was shown previously [46] with elevated 
levels for anxiety and depression 6 weeks and 3 months after 
diagnosis and normalization afterwards. In addition, BPPV 
shows a higher prevalence in the general population [38] and 
might, therefore, be overrepresented in our patient cohort.
The phobic postural sway pattern in posturography analy-
sis, which was the most common diagnostic finding (50%) 
in PPPD, is also noteworthy. This implies that most PPPD 
patients show typically poor performances during easy bal-
ance conditions (e.g., normal stance with eyes open and 
eyes closed) that improve with increasing difficulty or with 
additional cognitive tasks compared to healthy controls [26, 
48]. Furthermore, posturography represents a helpful tool 
for longitudinal monitoring of a possible transition from an 
acute vestibular disorder to chronic functional dizziness, as 
demonstrated earlier by Brandt and co-workers [25]. Con-
sequently, it appears advisable for all clinicians who do not 
have posturographic equipment available to clinically test 
stance performance also during more difficult and dual tasks 
[49].
The limitations of the current study are mainly its retro-
spective approach and a potential patient selection bias due 
to the referral of patients to a specialized tertiary center, 
which does not allow a transfer to the general population, 
especially in other countries. However, this study in a well-
diagnosed PPPD cohort showed considerable differences in 
terms of demographic and clinical aspects between p- and 
s-PPPD patients, thereby underlining the need for careful 
syndrome classification and further prospective studies in 
clearly characterized p- and s-PPPD subgroups.
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